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Lymph nodes (LNs) are important sentinel organs where antigen-presenting cells interact with T cells
to induce adaptive immune responses. In cutaneous infection of mice with Leishmania major, resistance
depends on the induction of a T-helper-cell-1 (Th1)-mediated cellular immune response in draining,
peripheral LNs. We investigated whether draining, peripheral LNs are absolutely required for resistance
against L. major infection. We investigated the course of experimental leishmaniasis in wild-type (wt) mice
lacking peripheral LNs (pLNs), which we generated by in utero blockade of membrane-bound lympho-
toxin, and in mice lacking pLNs or all LNs due to genetic deletion of lymphotoxin ligands or receptors. wt
mice of the resistant C57BL/6 strain without local skin-draining LNs were still able to generate specific
T-cell responses, but this yielded Th2 cells. This switch to a Th2 response resulted in severe systemic
infection. We also confirmed these results with mice lacking pLNs due to genetic depletion of lympho-
toxin-. The complete absence of LNs due to a genetic depletion of the lymphotoxin- receptor also
resulted in a marked deterioration of disease and a Th2 response. Thus, in the absence of pLNs, an L.
major-specific Th2 response is induced in the remaining secondary lymphoid organs, such as the spleen
and non-skin-draining LNs. This indicates a critical requirement for pLNs to induce protective Th1
immunity and suggests that whether Th1 or Th2 priming to the same antigen occurs depends on the site
of the primary antigen recognition.
Secondary lymphoid organs serve as sites of contact between
T cells, B cells, antigen-presenting cells (APCs), and follicular
dendritic cells (DC) within a highly structured and organized
environment. Antigen-specific T-cell responses are generated
within this environment. The spleen, LNs, Peyer’s patches
(PPs), and mucosa-associated lymphoid tissues are examples of
secondary lymphoid organs.
Cutaneous Leishmania major infection in mice (experimen-
tal leishmaniasis) is widely used as an example to study the
innate and adaptive immune responses toward infectious dis-
ease (25, 32, 39). A number of studies have demonstrated the
induction of a specific immune response after L. major infec-
tion in local skin-draining LNs (6, 20, 22, 31).
Resistance to L. major infection is linked to the ability to
mount an L. major-specific Th1 cell response, which leads to
the activation of macrophages for elimination of the oblig-
atory intracellular parasite. Thus, in resistant mice, such as
C57BL/6 mice, infection is transient and is controlled at the
site of primary infection. Susceptibility in BALB/c mice, on
the other hand, is associated with the development of an L.
major-specific Th2 response, which results in a failure to
control parasite growth and subsequent fatal visceral
spread.
Lymphotoxin (LT) is a member of the tumor necrosis factor
(TNF) cytokine family. While soluble LT3 homotrimers in-
teract with the TNF receptors I (p55) and II (p75), the LT12
heterodimer interacts exclusively with the membrane-bound
LT receptor (LTR). There is another ligand for the LTR,
called LIGHT (for lymphotoxin-like, exhibits inducible expres-
sion, competes with herpes simplex virus glycoprotein D for
HVEM, a receptor expressed by T lymphocytes), which can
also bind to the receptor HVEM (herpes virus entry mediator)
(40). LTR-mediated signaling is crucial for the development
of LNs and PPs during gestation (12, 27, 29).
LT- gene-deficient (/) mice lack most LNs and all PPs
except cervical and mesenteric LNs. The phenotype of these
mice includes additional alterations in the immune system,
which lead to disruption of splenic germinal center formation
and antibody responses (e.g., loss of splenic marginal zones
[MZ] and of follicular DC networks in spleen and LNs) (10, 11,
17, 18, 21).
LTR/ mice (12) lack PPs and LNs and have a profoundly
altered splenic architecture with ill-defined T- and B-cell areas.
In experimental leishmaniasis, peripheral LNs (pLNs) are
considered the organ where priming of L. major-specific T cells
occurs. We addressed the question of whether pLNs are abso-
lutely required for protective immunity against L. major in
genetically resistant C57BL/6 mice.
Therefore, we generated wild-type (wt) mice deficient in
pLNs. Signaling via LTR is crucial during gestation for the
development of LNs and PPs (12, 27, 29). Thus, blockade of
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membrane LT in utero during a certain time interval can irre-
versibly prevent development of LNs and PPs.
These organogenic defects in LN development are irre-
versible, while the architecture of the remaining secondary
lymphoid organs, including B-cell localization, integrity of
splenic MZ populations, and the expression of the addressins
MAdCAM-1 and peripheral node addressin, is restored in the
mesenteric, sacral, lumbar, and cervical LNs of the adult prog-
eny (26, 27).
In order to investigate whether the non-skin-draining LNs
present in wt mice lacking pLNs contribute to the development
of an L. major-specific immune response, we also studied the
course of L. major infection in LTR/ mice completely
lacking all LNs.
These models, together with the previously analyzed
LT/ mouse model and a transient blockade of LTR-
mediated signaling by LTR-immunoglobulin G (IgG) fusion
protein in wt mice, allowed us to distinguish between the roles
of LNs and of the LTR signaling pathway in the development
of the host defense against L. major.
Our data demonstrate that protection against L. major is
abrogated in wt C57BL/6 mice deficient in pLNs (and also in
C57BL/6 mice lacking all LNs) and that this abrogation is
associated with the generation of an L. major-specific Th2
response. In addition, the presence of mesenteric LNs was not
sufficient to induce resistance against L. major. Our results
show that local draining LNs are indispensable for the gener-
ation of an L. major-specific Th1 response.
MATERIALS AND METHODS
Mice. C57BL/6 wt mice were purchased from Jackson Laboratories (Bar
Harbor, ME). C57BL/6 LT/ mice were provided by N. Ruddle (Yale Uni-
versity, New Haven, CT). C57BL/6 LTR/ mice were provided by K. Pfeffer
(University of Du¨sseldorf, Du¨sseldorf, Germany). All mice were kept under
sterile conditions in microisolator cages in the animal facilities of the Mu¨nster
University Department of Dermatology with unlimited access to food and water
according to federal animal protection regulations (permits G5/99 and G78/
2000). Moribund mice were euthanized.
Generation of LTR-IgG fusion protein and treatment with LTR-IgG.
LTR-IgG was purified from supernatants of an LTR-IgG-expressing CHO
cell line using protein A affinity chromatography. Mice were intraperitoneally
injected with 100 g LTR-IgG once or twice weekly. In all experiments,
mice were injected with LTR-IgG 24 h prior to infection. Purified human
immunoglobulin (huIgG) was purchased from Biotest (Dreieich, Germany).
The biological efficiency of this treatment protocol in blocking LTR-medi-
ated signaling has previously been demonstrated with C57BL/6 mice infected
with Citrobacter rodentium (36) and was also tested using an LN ablation
protocol (27).
Gestational treatment of mice with LTR-IgG and anti-TNF antibody. Fe-
male C57BL/6 wt mice were screened daily for the presence of a vaginal plug as
a sign of conception. Pregnant mice were intravenously injected with 100 g
LTR-IgG and anti-TNF antibody TN3-19.12 (Abcam, Cambridge, United
Kingdom) on days 11, 13, 15, and 17 following conception. Progeny (male and
female) of gestationally treated mice were used at the age of 10 to 12 weeks for
L. major infection. At the end of infection experiments, mice were euthanized
and the presence of LNs was individually investigated. The progeny of all fusion
protein-treated mothers lacked popliteal, inguinal, and cervical LNs. Mesenteric
LNs could be detected in all of these mice.
Generation of chimeric mice. wt C57BL/6 and LTR/ mice received a lethal
dose of radiation (5.0 Gy on 2 days, resulting in a cumulative dose of 10 Gy) and
were reconstituted with bone marrow cells (107 cells/mouse) obtained from wt
C57BL/6 mice or from LTR/ mice. For experimental leishmaniasis, chimeric
mice were used 5 weeks after bone marrow reconstitution.
Cytokine and proliferation assay. For cytokine assay, mice were euthanized
and spleens were aseptically removed. A single-cell suspension was prepared,
and CD4 T cells were collected using biomagnetic enrichment procedures
(Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer’s
recommendations.
Bone marrow-derived DC were generated as previously described (35). Shortly
thereafter, the femur bone was aseptically removed from euthanized C57BL/6
mice and the bone marrow was flushed out. Bone marrow DC were expanded
with interleukin 4 (IL-4) and granulocyte-macrophage colony-stimulating factor
for 6 days. DC (1  106 cells/ml) were incubated with soluble leishmania antigen
equivalent to 5  106 L. major organisms for 48 h. For assessment of cytokine
secretion, DC and CD4 T cells (5  104/100 l) were mixed in a 1:5 ratio and
cultured in RPMI 1640 plus 2 mM glutamine, 50 M mercaptoethanol, and 10%
fetal calf serum for 48 h. Culture supernatants were assayed by enzyme-linked
immunosorbent assay (ELISA) (Pharmingen) for IL-4 (detection limit, 14
pg/ml) and gamma interferon (IFN-) (detection limit, 2.5 pg/ml) according to
the manufacturer’s instructions.
Parasites and experimental infection. L. major (WHO nomenclature MHOM/
IL/81/FE/BNI) was cultivated in Schneider’s drosophila medium supplemented
with 10% fetal calf serum, 2% human urine, 2% glutamine, and 1% penicillin-
streptomycin (14). Soluble leishmania antigen was prepared by five repeated
freeze and thaw cycles in phosphate-buffered saline.
Experimental leishmaniasis. Cutaneous leishmaniasis was initiated by subcu-
taneous application of 2 107 promastigotes (stationary phase) of L. major in 50
l phosphate-buffered saline into the left hind footpad of 4 to 14 mice per
experimental group. In additional experiments, smaller parasite inocula (105 and
106 stationary-phase promastigotes) and 2  107 nonviable L. major organisms
were used. The latter were obtained by three repeated freeze-thaw cycles with
living parasites. Footpad thickness was assessed weekly using a metric caliper.
Specific swelling of the infected footpad was assessed by subtracting the diameter
of the infected footpad from that of the noninfected footpad. The course of
infection was monitored for 8 to 12 weeks. When mice developed significant foot
ulcers, the experiment was terminated instantly and the mice were euthanized.
Footpads, bone marrow, liver, and spleen from each mice were harvested for
limiting dilution assay (LDA) and determination of the cytokine profile. The
experiments were repeated two to three times.
LDA. Parasite numbers in bone marrow and liver as a parameter for systemic
spread were determined 8 to 12 weeks after infection by an LDA (37) modified
by using leishmania medium as specified above instead of slant blood agar (8).
Statistical analysis. Means and standard errors (SE) of the means of all
numerical data were calculated. Statistical significance between groups was
judged by either the Mann-Whitney U test or Student’s t test. A comparison of
data sets yielding a P value of 	0.05 was considered to not be statistically
significant.
RESULTS
Mice lacking pLNs are susceptible to L. major infection and
show an L. major-specific Th2 response. wt mice lacking pLNs
were generated by gestational blockade of membrane-bound
lymphotoxin by injection of LTR-IgG and anti-TNF antibody
on days 11, 13, 15, and 17 following conception. Their offspring
were infected with stationary-phase L. major promastigotes,
and the lack of pLNs was confirmed in each mouse after
sacrifice. In these mice, lesions progressed further than in
control mice (Fig. 1A). Ten weeks after infection, lesions had
nearly completely resolved in control mice, as expected, while
in wt mice lacking pLNs, chronic lesions with occasional
small ulcers had developed. Correspondingly, wt mice lack-
ing pLNs harbored markedly more parasites in cutaneous
lesions (Fig. 1B).
To analyze whether in wt mice lacking pLNs the course of
disease was also qualitatively altered with regard to viscer-
alization, we determined parasite numbers in liver and bone
marrow to detect systemic infection. As depicted in Fig. 1C
and D, wt mice lacking pLNs harbored high numbers of
parasites in liver and bone marrow, while, as expected, there
was no systemic dissemination in control mice. Since suffi-
cient differentiation and propagation (9, 33) of Th1 cells are
indispensable for resistance to L. major infection, we ana-
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lyzed cytokine production by CD4 T cells. As shown in Fig.
1E and F, wt mice lacking pLNs secreted larger amounts
IL-4 while the production of IFN- was markedly reduced
compared to results with control mice. In conclusion, wt
mice lacking pLNs present an L. major-specific immune
response despite the lack of pLNs; however, the absence of
pLNs was associated with a switch from Th1 toward Th2
differentiation.
FIG. 1. (A) Footpad swelling (compared to the uninfected contralateral footpad) (mm) of wt mice lacking pLNs (pLN_null) generated by
gestational treatment with anti-TNF and LTR-IgG fusion protein (see Materials and Methods) and control C57BL/6 (C57 control) mice (mean

SE; n  13 for wt mice lacking pLNs; n  7 for C57BL/6). (B to D) LDA of footpads (B), liver (C), or bone marrow (D) of wt mice lacking pLNs
or control C57BL/6 mice (C57 control) 10 weeks after infection. The number of living parasites for single mice (diamonds) and the means for wt
mice lacking pLN and C57BL/6 mice (horizontal bar) are indicated. (E and F) Cytokine secretion of CD4 cells isolated from spleens of wt mice
lacking pLNs or control C57BL/6 mice 10 weeks after infection. Cells were incubated for 48 h with syngeneic DC stimulated for 48 h with soluble
Leishmania antigen (sLmAg) (filled bars) or with unstimulated syngeneic dendritic cells (w/o Ag) (open bars). IFN- (E) or IL-4 (F) secretion was
measured by ELISA (mean 
 SE; n  5). For all panels: *, P  0.05; **, P  0.01; ***, P  0.001 (for differences between wt mice lacking pLNs
and control C57BL/6 mice).
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Mice lacking LNs due to genetic depletion of lymphotoxin
ligands or receptors are susceptible to L. major infection and
show Th2-cell differentiation. In wt mice lacking pLNs, non-
skin-draining mesenteric LNs are still present. To clarify
whether the presence of these LNs is responsible for the ob-
served Th2 differentiation, we analyzed the course of L. major
infection in LTR/ mice, which completely lack LNs, in-
cluding mesenteric LNs.
As shown in Fig. 2A, lesions were markedly progressive in
LTR/ mice. The progression of lesions was similar to that
observed in the prototypically susceptible BALB/c mice. Con-
versely, there was regression of lesions in control C57BL/6 wt
mice 6 weeks after infection, as expected.
Accordingly, footpads of LTR/ mice contained as many
parasites as those of susceptible BALB/c mice (up to 1 
105-fold more parasites than in wt C57BL/6 mice) (Fig. 2B).
FIG. 2. (A) Footpad swelling (compared to the uninfected contralateral footpad) (mm) of infected LTR/, LT/, wt C57BL/6 (C57/),
and BALB/c mice (mean 
 SE; n  9 for C57BL/6 wt and LT/ mice; n  8 for LTR/ and BALB/c mice). 1, P  0.05; 2, P  0.01 (for
differences between LTR/ and LT/ mice). *, P  0.05; **, P  0.01; ***, P  0.001 (compared to results for wt C57BL/6 mice). (B to
D) LDA of footpads (B), liver (C), or bone marrow (D) of LTR/, LT/, wt C57BL/6 (C57/), or BALB/c mice 10 weeks after infection.
The number of living parasites for single mice (diamonds) and the means for LTR/, LT/, wt C57BL/6, and BALB/c mice (horizontal bars)
are indicated. (E and F) Cytokine secretion of CD4 cells isolated from spleens of LTR/, LT/, wt C57BL/6 (C57/), or BALB/c mice
10 weeks after infection. Cells were incubated for 48 h with syngeneic DC stimulated for 48 h with soluble Leishmania antigen (sLmAg) (filled bars)
or with unstimulated syngeneic DC (open bars). IFN- (E) or IL-4 (F) secretion was measured by ELISA (mean 
 SE; n  5). For panels B to
F: *, P  0.05; **, P  0.01; ***, P  0.001 (for differences between indicated mice).
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Moreover, high numbers of parasites were detected in livers
and bone marrow of LTR/ mice, as was found for BALB/c
mice (Fig. 2C and D).
To clarify the contribution of T-helper-cell differentiation in
the deficient parasite containment, we analyzed the presence
and extent of an L. major-specific T-cell response 10 weeks
after infection (Fig. 2E and F).
For LTR/ mice, we found an L. major-specific IL-4
secretion which was as high as that for BALB/c mice.
Since even in susceptible BALB/c mice there is a higher
absolute concentration of released IFN- than of IL-4, the
degree of Th1 or Th2 response can best be expressed as the
ratio of released antigen-specific IFN- to IL-4.
This ratio revealed that the Th2 response was indeed as
strong in LTR/ mice as in BALB/c mice due to equal
IFN- secretion.
Thus, LTR/ mice, which revealed the same degree of
parasite dissemination as BALB/c mice, also presented the
same strong Th2 switch.
Experimental leishmaniasis has previously also been ana-
lyzed with LT/ mice. These mice resemble wt mice lacking
pLNs, since they lack pLNs and develop mesenteric LNs. Mu-
cosa-draining cervical and sacral LNs are present in LT/
mice. Like wt mice lacking pLNs, LT/ mice were shown to
develop a spread of parasites to visceral organs, but they were
not reported to develop a Th2 switch.
In comparison with our results, this could mean that the Th2
switch is prevented by the presence of mucosa-draining cervi-
cal and sacral LNs, the only lymphoid organs present in
LT/ mice but not in wt mice lacking pLNs and also not in
LTR/ mice.
When we analyzed infection in these mice, we found that in
similarity to wt mice lacking pLNs, they developed stable but
nonhealing lesions with occasional small ulcers (Fig. 2A) and
also visceralization (Fig. 2B). In agreement with Xu et al. (42),
we found lower antigen-specific IFN- secretion in LT/
mice, but in contrast to previously published data, we detected
a marked, antigen-specific secretion of IL-4 by CD4 T cells
derived from LT/ mice (Fig. 2E and F). IL-4 levels were
significantly higher than those in wt C57BL/6 mice, where
antigen-induced IL-4 secretion was barely detectable (the
IFN/IL-4 ratio in C57BL/6 wt mice is approximately 250,
versus 2.7 in BALB/c mice, while the values are 15 for LT/
mice and 2.3 for LTR/ mice). This clearly indicates that a
switch toward a Th2 response pattern had occurred in LT/
mice, associated with systemic disease in these mice.
The Th2 response in LN-deficient mice occurs early after
infection and also after injection of nonviable parasites. It
could be argued that the Th2 switch observed in LN-deficient
mice is a consequence rather than the cause for susceptibility,
since it could be due to constant and prolonged L. major
stimulation. To address this issue, we also analyzed cytokine
production in LTR/ and C57BL/6 wt mice very early after
infection, when there was no apparent difference in the clinical
course of disease. As such, we already observed a clear L.
major-specific Th2 response pattern, with lower IFN- secre-
tion and higher IL-4 levels than were found for C57BL/6 wt
mice (Fig. 3A and B), 2 weeks after infection. To further
exclude an influence of uncontrolled parasite growth on Th2
differentiation, we injected parasites killed by repeated freeze-
thaw cycles into LTR/ and C57BL/6 wt mice and measured
L. major-specific cytokine production 2 weeks later. We de-
FIG. 3. (A and B) Cytokine secretion of CD4 cells isolated from spleens of LTR/ or wt C57BL/6 (C57 /) mice 2 weeks after L. major
infection. Cells were incubated for 48 h with syngeneic DC stimulated for 48 h with soluble Leishmania antigen (filled bars) or with unstimulated
syngeneic DC (open bars). IFN- (A) or IL-4 (B) secretion was measured by ELISA (mean 
 SE; n  3). (C and D) Cytokine secretion of CD4
cells isolated from spleens of LTR/ or wt C57BL/6 (C57 /) mice 2 weeks after injection of 2  107 nonviable L. major parasites. Cells were
incubated for 48 h with syngeneic DC stimulated for 48 h with soluble Leishmania antigen (filled bars) or with unstimulated syngeneic DC (open
bars). IFN- (C) or IL-4 (D) secretion was measured by ELISA (mean 
 SE; n  3). For all panels: *, P  0.05; **, P  0.01; ***, P  0.001
(for differences between indicated mice).
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tected L. major-specific cytokine secretion in LTR/ and
C57BL/6 wt mice, which was clearly shifted toward a Th2
response pattern in LTR / mice (Fig. 3C and D). These
experiments indicate that Th2 differentiation is not secondary
to susceptibility in LN-deficient mice but is likely to be the
cause of the observed susceptibility in these mice.
Infection of LTR/ mice with smaller L. major inocula
also induces a Th2 response. Different numbers of parasites
used to initiate an infection can have a distinct impact on the
course of infection (3, 4, 38). Moreover, with use of large
parasite inocula, an early dissemination of parasites beyond
the local lymph nodes has been linked to susceptibility in
BALB/c mice (20). A DC-independent transport of L. major
antigen to skin-draining LNs resulting in initiation of an adap-
tive immune response by LN-resident DC populations has
been reported (15, 22). To test whether the observed Th2
switch in LN-deficient mice is related to a DC-independent
parasite dissemination as a result of the high-dose infection, we
also infected LTR/ and C57BL/6 wt mice with 105 (data
not shown) and 104 (Fig. 4) promastigote parasites. While the
FIG. 4. (A) Footpad swelling (compared to the uninfected contralateral footpad) (mm) of LTR/ and wt C57BL/6 (C57/) mice infected
with a small parasite inoculum (104 parasites) (mean 
 SE; n  4 for LTR/ mice and n  5 for C57/ mice). *, P  0.05; **, P  0.01;
***, P  0.001 (compared to wt C57BL/6 mice). (B to D) LDA of footpads (B), spleen (C), or bone marrow (D) of LTR
/ or control C57BL/6
wt (C57 /) mice 11 weeks after infection. The number of living parasites for single mice (diamonds) and the means for LTR/ and wt
C57BL/6 mice (horizontal bars) are indicated. (E and F) Cytokine secretion of CD4 cells isolated from spleens of LTR/ and wt C57BL/6
(C57/) mice 11 weeks after infection. Cells were incubated for 48 h with syngeneic DC stimulated for 48 h with soluble Leishmania antigen
(sLmAg) (black bars) or with unstimulated syngeneic DC (open bars). IFN- (E) or IL-4 (F) secretion was measured by ELISA (mean 
 SE; n 
3). For all panels: *, P  0.05; **, P  0.01; ***, P  0.001 (for differences between LTR
/ and wt C57BL/6 mice).
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course of infection was prolonged, as expected, due to the
smaller parasite inocula, we did not observe any differences in
Th2 differentiation (Fig. 4E and F), local parasite containment
(Fig. 4B), and visceralization (Fig. 4C and D) compared to
results with the high-dose infection model. Thus, Th2 differ-
entiation was not restricted to large parasite inocula in LN-
deficient mice.
LTR-mediated signaling has no effect on L. major infec-
tions. In contrast to results with wt mice lacking pLNs, the
genetic models present with alterations of LTR-mediated
signaling during infection. In LTR/ mice, LTR-mediated
signaling is completely abolished, while in LT/ mice,
LIGHT, a second ligand of the LTR, can still bind to the
receptor (40). LTR is expressed on monocytic cells, and
the relevance of LTR-mediated signaling for the course of
adaptive and innate immune responses has previously been
reported (7, 34).
Therefore, we cannot exclude an influence of LTR-medi-
ated signaling on L. major infection in these genetically de-
pleted mice.
In order to exclude an influence of LIGHT-LTR signaling
on the course of L. major infection which is not secondary to
the lack of pLNs, we treated control C57BL/6 wt mice repeat-
edly with LTR-IgG prior to and during L. major infection. As
shown in Fig. 5A and B, we detected no influence of LTR-
IgG treatment on footpad swelling, parasite load in feet (Fig.
5B), and prevention of parasite dissemination (data not
shown).
Thus, in the presence of pLNs, we could not detect an
influence of LIGHT-LTR signaling on L. major infection.
In agreement with these data, we further showed that the
presence of LTR on monocytes and other hematopoietic cells
has no decisive influence on the high susceptibility of LTR/
mice: in wt-to-LTR bone marrow chimeric (wt3LTR) mice,
we detected systemic disease similar to that in LTR mice (log
parasites in footpads, 6.7 for wt3LTR mice versus 7.8 for
LTR/ mice; in liver, 6.4 versus 6.5; in bone marrow, 4.0
versus 4.5). wt3LTR mice developed a Th2 response with
high levels of antigen-specific IL-4 (IFN/IL-4 ratio, 12.6, ver-
sus 5.3 in LTR/ mice and 381 in control C57BL/6 wt mice).
Correspondingly, an absence of LTR on hematopoietic cells
had no decisive impact on the course of infection in LTR/-to-wt
bone marrow chimeric (LTR3wt) mice. LTR3wt mice
developed a Th1 response like that of wt C57BL/6 mice (IFN/
IL-4 ratio of 376, versus 389 in control C57BL/6 wt mice). In
agreement with this, there was no dissemination to the spleen,
liver, or bone-marrow in LTR3wt mice as in control mice
and we found no significant differences in the local parasite
burden (log parasites in footpads, 5.2 in LTR3wt mice ver-
sus 4.5 in control wt C57BL/6 mice).
The spleen is dispensable for resistance to cutaneous L.
major infections. An antigen-specific immune response after
subcutaneous infection with L. major is also generated in mice
lacking all LNs (LTR/ mice). This suggests that in the
absence of LNs, T-cell priming must then take place in the
spleen, resulting in Th2 cells. Therefore, in C57BL/6 mice with
draining LNs but without a spleen, skin-draining LNs should
suffice to induce a protective Th1 response. To test this hy-
pothesis, we infected splenectomized and sham-operated
C57BL/6 mice with L. major.
We detected no influence of splenectomy on footpad swell-
ing (data not shown) and parasite clearance in L. major infec-
tion (log parasites in footpads of splenectomized mice, 6.2,
versus 5.9 in sham-operated mice). There was no evidence for
L. major dissemination in splenectomized mice.
DISCUSSION
In the absence of skin-draining LNs, infection of C57BL/6
mice with L. major results in an L. major-specific T-cell re-
sponse. However, despite the genetically resistant background,
the infection is associated with a Th2 response and systemic
dissemination of parasites. The presence of non-skin-draining
LNs in these mice was not sufficient to induce resistance
against L. major. Therefore, our results clearly indicate that for
the generation of an L. major-specific Th1 response, the pres-
ence of skin-draining LNs appears to be indispensable.
The nature of an immune response has been thought to
classically depend on two signals: (i) the antigen and (ii) the
costimulatory signals. More recently a third signal has been
proposed, consisting of additional signals by DC triggered via
the local cytokine milieu (16). Our results strongly suggest that
the secondary lymphatic organs utilized for antigen presenta-
tion provide a fourth signal which critically influences the type
of T-cell response.
These results were obtained by using mice with a resistant
C57BL/6 background, which were made deficient in skin-drain-
ing peripheral LNs by gestational treatment with LTR-IgG
FIG. 5. (A) Footpad swelling (compared to the uninfected con-
tralateral footpad) (mm) of LTR-IgG fusion protein-treated
(LTRlgG) or human IgG-treated (HuIgG) C57BL/6 mice (mean 

SE; n  5). (B) LDA of footpads of LTR-IgG fusion protein-treated
or huIgG-treated C57BL/6 mice 12 weeks after infection. The number
of living parasites for single mice (diamonds) and the means (horizon-
tal bars) are indicated.
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and anti-TNF. After such treatment, mice with the BALB/c
background had already been demonstrated to be able to gen-
erate normal antigen-specific T-cell responses against small
antigens in the contact hypersensitivity model. The morpho-
logical and functional composition of the remaining lymphoid
organs (mucosal and mesenteric lymph nodes and spleen) was
not influenced, nor were the prerequisites for direct interac-
tions between T cells and APCs decisively impaired (28).
In our study, we also used mice with genetic depletions of
LT signaling components (LT/ and LTR/ mice). This
allowed us to compare the immune response of wt mice lacking
pLNs with those of mice that completely lack LNs and mice
that lack pLNs but develop mucosa-draining cervical and sa-
cral LNs (LT/ mice).
The effect of draining LNs on the course of Leishmania
infection has been analyzed in one previous study, but there,
LNs were surgically removed from BALB/c mice. Infection
with L. major in these mice resulted in more-severe disease
(24), but these results are difficult to interpret because surgical
removal of LNs also entails disruption of lymph vessels. In
contrast, our procedure allowed us to analyze the effect of the
absence of secondary lymphoid organs on the T-cell-depen-
dent immune response in the presence of intact lymphatic
vessels.
The importance of different routes of infection has been
analyzed in two previous studies. Intranasal infection of resis-
tant C57BL/6 mice was associated with a Th2 immune re-
sponse (5). A shift toward a Th2 response was also observed in
(C57BL/6  BALB/c) F1 mice when mice were infected in the
dorsal skin instead of the footpad (23).
Mesenteric LNs are known to favor a Th2 response. As such,
ovalbumin-pulsed DC derived from pLNs induce a Th1 re-
sponse, while DC derived from mesenteric LNs induce a Th2
response (2).
Therefore, the type of T-cell response and the ensuing
course of L. major infection may depend on the site of antigen
delivery, partly because of the type of APCs utilized for antigen
presentation (2, 5, 23).
A recent study demonstrates that in subcutaneous infection,
as applied in our model, the predominant uptake and transport
of L. major to draining LNs is mainly executed by dermal DC
and not by epidermal Langerhans cells (31). This is important,
since dermal DC, in contrast to Langerhans cells, have been
demonstrated to enter the spleen for antigen presentation
(28). Recently, a rapid, DC-independent transport of parasite
antigen and living parasites to skin-draining LNs using high-
dose infection has been reported (22). Moreover, LN-resident
cells rather than skin-derived DC have been demonstrated to
induce a T-cell response directed against the L. major antigen
LACK (Leishmania homolog for receptors of activated C ki-
nase) in the high-dose infection model (15). Early parasite
dissemination beyond the local LNs has previously been linked
to susceptibility in BALB/c mice. Therefore, we also analyzed
L. major infection in LTR/ mice infected with small par-
asite inocula, having thus a much lesser probability of DC-
independent parasite dissemination. Using small parasite in-
ocula, we observed no differences from high-dose infection,
indicating that the observed Th2 switch is not restricted to
large parasite inocula. Thus, an effect of the absence of T-cell
priming by LN-resident DC in LN-deficient mice on the ob-
served Th2 switch cannot be excluded but seems unlikely. Ad-
ditionally, since T-cell priming by LN-resident DC resulted in
a Th2 response in susceptible and resistant mice (22), the
absence of this mechanism in LN-deficient mice cannot easily
explain the observed Th2 switch.
Since an L. major-specific immune response was induced in
mice deficient in peripheral lymph nodes, it appears likely that
T-cell priming has taken place in the spleen or in the remaining
nondraining mesenteric LNs.
Recent studies demonstrate that in the absence of certain
secondary lymphoid organs, a specific immune response can
indeed be induced in the remaining lymphoid organs, including
the spleen. As such, in the absence of draining LNs, dermal DC
were shown to still be able to induce a contact hypersensitivity
response after subcutaneous administration of hapten. When
antigen was applied epicutaneously, a single mesenteric LN
was sufficient to induce contact hypersensitivity (28). In trans-
plant rejection there was an overlapping requirement for the
spleen or LNs (19).
To clarify how far the presence of different non-skin-drain-
ing LNs is responsible for Th2 differentiation in wt mice
lacking pLNs, we had additionally analyzed experimental
leishmaniasis in LTR/ mice, which completely lack LNs,
and in LT/ mice, which closely resemble wt mice lacking
pLNs but which still develop mucosa-draining cervical and
sacral LNs.
Experimental leishmaniasis has previously been analyzed
with the latter and shown to result in systemic infection. Pre-
vious studies showed either no differences in Th differentiation
or a reduction in IFN- secretion without increased IL-4 re-
lease (41, 42).
In contrast to findings of Xu et al. (42) and Wilhelm et al.
(41), however, we detected a clear Th2 response in LT/
mice.
The different results regarding IL-4 are most likely due to
the methods used for analyzing the T-cell response. Wilhelm et
al. (41) were analyzing cytokine mRNA expression in splenic
cells when they found no alterations in Th differentiation,
while Xu et al. (42) were stimulating whole-spleen-cell popu-
lations with L. major antigen when they reported no IL-4
secretion. We analyzed the cytokine response of isolated
CD4 T cells and were able to detect a marked IL-4 secretion
after stimulation with Leishmania antigen-primed DC.
Thus, we conclude that in LT/ mice, just as in wt mice
lacking pLNs, a Th2 response is induced in the remaining
non-skin-draining LNs or the spleen.
It could be argued that the Th2 switch observed in all LN-
deficient mice analyzed in this study is not the cause for sus-
ceptibility but may be a consequence of constant and pro-
longed L. major stimulation. However, a Th2 cytokine
response pattern was detected very early in L. major-infected
LTR/ mice and also after inoculation with nonviable par-
asites. This clearly supports our conclusion that susceptibility
in LN-deficient mice is a consequence of early Th2 differenti-
ation due to the absence of pLNs.
While our results suggest that LNs are indispensable for an
L. major-specific Th1 response, the spleen appears to be dis-
pensable for a protective Th1-type immunity against L. major
in the presence of pLNs. We could show that splenectomized
wt mice cleared L. major similarly to sham-operated mice.




arch 18, 2014 by W







The question remained of whether in LTR- or LT-defi-
cient mice it was the absence of pLNs which led to a Th2 switch
or rather the alterations in LTR-mediated signaling.
In LTR-deficient mice, LTR-mediated signaling is com-
pletely abolished, while in LT/ mice, LIGHT, a second
ligand of the LTR, can still bind to the receptor (40). LTR
is expressed on monocytic cells, and LTR-mediated signaling
influences the course of adaptive and innate immune responses
(7, 34). Recently LIGHT has been reported to be important
for IL-12 production of DC and resistance in experimental
leishmaniasis (43). However, the authors argue that these ef-
fects are primarily mediated by binding of LIGHT to the
HVEM receptor.
This raises the question of impaired DC or macrophage
function as a cause distinct from the absence of secondary
lymphoid tissues. There are several observations which argue
against this hypothesis: no alterations in DC and macrophage
functions were described for mice deficient in lymphotoxin
ligands and receptors (1, 30, 42). In similarity to previously
published data regarding LT/ mice (41), we observed no
decisive effect on infection following transfer either of
LTR/ bone marrow to wt mice or wt bone marrow to
LTR/ mice. Therefore, the lack of LTR expression on
bone marrow-derived APC does not interfere with immunity
against L. major infection, and the presence of the LTR on
bone marrow-derived cells was not sufficient to induce resis-
tance. Furthermore, in contrast to the findings of Xu et al. (43),
we could not demonstrate that interruption of LTR-mediated
signaling by LTR-IgG treatment prior to and during infection
affected resistance to L. major in control (C57BL/6 wt) mice.
All of these results provide no evidence for a dominant role
of LTR-mediated signaling in experimental leishmaniasis.
In conclusion, we have demonstrated for the first time that
L. major infection in the absence of pLNs in mice of resistant
background (C57BL/6) results in a Th2 immune response and
susceptibility. Thus, in contrast to pLNs, the lymphoid micro-
environment of mucosa-draining LNs and/or the spleen results
in the formation of Th2 effector cells, which fail to control
leishmaniasis.
The Th2 bias of these lymphoid organs may comprise a
physiological mechanism for antigens which enter the organ-
ism via the intestine or the systemic circulation. In both cases,
induction of Th1-type cell-mediated immunity would result in
severe tissue damage. Thus, our data indicate that the initia-
tion of a tissue-adapted immune response is controlled at two
sites: at the tissue itself by the local microenvironment and/or
different populations of DC (13) and at the draining lymphatic
organs. The mechanism by which lymphoid organs regulate
T-cell differentiation might be signals either from LN stroma
cells or from the T-cell and DC populations present in the
organ.
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